MedTrace Logo

Safety Study of Stopping Thromboprophylaxis Based on Ultrasound Results After Total Knee Replacement

NCT00362492 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 850

Last updated 2010-10-28

No results posted yet for this study

Summary

The purpose of this study is to determine whether stopping Low Molecular Weight Heparin (LMWH) thromboprophylaxis is safe after total knee joint replacement. The investigators select patients without proximal thromboembolism assessed by bilateral venous ultrasound examination 7-10 days after surgery. the investigators hypothesis is that stopping thromboprophylaxis is equally effective than prolonging thromboprophylaxis in order to prevent post-surgery complications in this population.

Conditions

  • Thromboembolism
  • Arthroplasty Replacement, Knee

Interventions

PROCEDURE

Bilateral ultrasound examination 7+/- 2 after surgery

Sponsors & Collaborators

  • University Hospital, Caen

    lead OTHER

Principal Investigators

  • Marie-Thérèse Barrellier, MD · Côte de Nacre University hospital

  • Claude Vielpeau, MD · Côte de Nacre University hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
46 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Completion
2007-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00362492 on ClinicalTrials.gov